These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 34308495
1. Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia. Grainger JD, Kühne T, Hippenmeyer J, Cooper N. Ann Hematol; 2021 Sep; 100(9):2143-2154. PubMed ID: 34308495 [Abstract] [Full Text] [Related]
2. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia. Lozano ML, Godeau B, Grainger J, Matzdorff A, Rodeghiero F, Hippenmeyer J, Kuter DJ. Expert Rev Hematol; 2020 Dec; 13(12):1319-1332. PubMed ID: 33249935 [Abstract] [Full Text] [Related]
8. Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study. Neunert C, Despotovic J, Haley K, Lambert MP, Nottage K, Shimano K, Bennett C, Klaassen R, Stine K, Thompson A, Pastore Y, Brown T, Forbes PW, Grace RF, Pediatric ITP Consortium of North America (ICON). Pediatr Blood Cancer; 2016 Aug; 63(8):1407-13. PubMed ID: 27135461 [Abstract] [Full Text] [Related]
9. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury. Watanabe R, Tabayashi T, Tomikawa T, Sagawa M, Anan-Nemoto T, Kimura Y, Takahashi Y, Tokuhira M, Otaki S, Oi H, Sawano M, Sugiyama S, Kizaki M. Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451 [Abstract] [Full Text] [Related]
17. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP]. Mori M, Kato M, Koh K, Hanada R. Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675 [Abstract] [Full Text] [Related]